Stock Events

Stock Events

Hitech Group Australia 

A$1.2100
10
-A$0.08-6.56% Friday 04:17

Statistics

Day High
1.24
Day Low
1.19
52W High
1.895
52W Low
0.8
Volume
6,883
Avg. Volume
14,345
Mkt Cap
51.18M
P/E Ratio
7.83
Dividend Yield
7.02%
Dividend
0.09

Upcoming

Dividends

7.02%Dividend Yield
Sep 26
A$0.04
Mar 26
A$0.05
Sep 25
A$0.05
Mar 25
A$0.05
Sep 24
A$0.05
10Y Growth
N/A
5Y Growth
3.5%
3Y Growth
-4.77%
1Y Growth
-5%

Earnings

18AugExpected
Q2 2023
Q4 2023
Q2 2024
Q4 2024
Q2 2025
Q4 2025
Q2 2026
999
333
-333
-999
Expected EPS
N/A
Actual EPS
N/A

Financials

6.2%Profit Margin
Profitable
2020
2021
2022
2023
2024
2025
99.07MRevenue
6.14MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow HIT.AU. It's not an investment recommendation.
GQG Partners
3
GQG.AU
Microsoft
2
MSFT
Alphabet
2
GOOGL
Coca-Cola
2
KO

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
CSL
CSL.AU
Mkt Cap58.85B
CSL Limited is a global biotechnology leader that develops and delivers innovative biotherapies and influenza vaccines, directly competing in the biotech sector with Hitech Australia.
Cochlear
COH.AU
Mkt Cap7.95B
Cochlear Limited offers implantable hearing solutions, competing with Hitech Australia in the medical devices segment, particularly in innovative health technologies.
Resmed
RMD.AU
Mkt Cap43.56B
ResMed Inc. specializes in the design, manufacture, and marketing of products for the treatment of sleep disorders and respiratory issues, overlapping with Hitech Australia's healthcare technology focus.
Fisher & Paykel Healthcare Limited
FPH.NZ
Mkt Cap0
Fisher & Paykel Healthcare Corporation Limited is a leading designer, manufacturer, and marketer of products and systems for use in respiratory care, acute care, and the treatment of obstructive sleep apnea, competing in similar healthcare technology markets as Hitech Australia.
Nanosonics Limited
NAN.AU
Mkt Cap965.48M
Nanosonics Ltd. is involved in the research, development, and commercialization of infection control and decontamination products and technologies, competing with Hitech Australia in the healthcare sterilization technology market.
Mesoblast
MSB.AU
Mkt Cap2.9B
Mesoblast Limited is a world leader in developing allogeneic cellular medicines for inflammatory ailments, competing with Hitech Australia in the biopharmaceutical sector.
AVITA Medical
AVH.AU
Mkt Cap180.04M
Avita Medical Ltd. provides regenerative medicine solutions, which competes with Hitech Australia's interests in innovative medical treatments and technologies.
Pro Medicus
PME.AU
Mkt Cap20.59B
Pro Medicus Limited offers medical imaging software and services, competing with Hitech Australia in the healthcare IT and medical imaging sectors.
Imugene
IMU.AU
Mkt Cap41.59M
Immutep Limited is active in the biotechnology field, focusing on immunotherapy products for cancer and autoimmune diseases, which places them in competition with Hitech Australia's biotech endeavors.

About

Established in 1993 and headquartered in Sydney, Australia, HiTech Group Australia Limited specializes in talent acquisition, connecting permanent and contract professionals with the Information and Communications Technology (ICT) sector throughout Australia's public and private domains. A key service involves deploying skilled ICT contractors to fulfill clients' temporary or project-specific staffing requirements. The company's expertise extends beyond technology, providing staffing solutions for other fields such as office administration, sales and marketing, and finance. Moreover, HiTech Group supports government agencies by delivering specialized digital services for the initiation and execution of digital transformation projects. Its diverse clientele includes major players in telecommunications, finance, healthcare, consulting, IT, and fast-moving consumer goods (FMCG), in addition to federal and state government entities.
Show more...
CEO
Elias Hazouri
Employees
17
Country
Australia
ISIN
AU000000HIT1

Listings

AU
AU
HIT.AU

0 Comments

Share your thoughts

FAQ

What is Hitech Group Australia stock price today?▼
The current price of HIT.AU is A$1.21 AUD — it has decreased by -6.56% in the past 24 hours. Watch Hitech Group Australia stock price performance more closely on the chart.
What is Hitech Group Australia stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on Australia Exchange exchange Hitech Group Australia stocks are traded under the ticker HIT.AU.
Is Hitech Group Australia stock price growing?▼
HIT.AU stock has fallen by -3.2% compared to the previous week, the month change is a -8.33% fall, over the last year Hitech Group Australia has showed a -33.88% decrease.
What is Hitech Group Australia market cap?▼
Today Hitech Group Australia has the market capitalization of 51.18M
When is the next Hitech Group Australia earnings date?▼
Hitech Group Australia is going to release the next earnings report on February 17, 2027.
What is Hitech Group Australia revenue for the last year?▼
Hitech Group Australia revenue for the last year amounts to 99.07M AUD.
What is Hitech Group Australia net income for the last year?▼
HIT.AU net income for the last year is 6.14M AUD.
Does Hitech Group Australia pay dividends?▼
Yes, HIT.AU dividends are paid semi-annual. The last dividend per share was 0.05 AUD. As of today, Dividend Yield (FWD)% is 7.02%.
How many employees does Hitech Group Australia have?▼
As of September 06, 2026, the company has 17 employees.
In which sector is Hitech Group Australia located?▼
Hitech Group Australia operates in the Manufacturing sector.
When did Hitech Group Australia complete a stock split?▼
Hitech Group Australia has not had any recent stock splits.
Where is Hitech Group Australia headquartered?▼
Hitech Group Australia is headquartered in Sydney, Australia.